AU Patent

AU2014252808A1 — The treatment of inflammatory disorders

Assigned to Cresset Biomolecular Discovery Ltd · Expires 2015-11-12 · 11y expired

What this patent protects

The present invention provides Nalidixic acid and analogues of Nalidixic acid for use in the treatment of inflammatory disorders.

USPTO Abstract

The present invention provides Nalidixic acid and analogues of Nalidixic acid for use in the treatment of inflammatory disorders.

Drugs covered by this patent

Kalydeco (IVACAFTOR) · Vertex Pharms Inc

Patent Metadata

Patent number: AU2014252808A1
Jurisdiction: AU
Classification: —
Expires: 2015-11-12
Drug substance claim: No
Drug product claim: No
Assignee: Cresset Biomolecular Discovery Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.